Boehringer Ingelheim Vetera GoldXP Equine Vaccine 1 mL/1 Dose
$64.45
Vetera GoldXP is a combination vaccine is for use in healthy horses 4 months of age and older as an aid in the prevention of disease caused by: Equine Influenza Virus (type A2), Equine Encephalomyelitis (Eastern and Western), Equine Rhinopneumonitis (EHV-1 and EHV-4), Tetanus and West Nile Virus.
**Ships Monday thru Thursday Only**
See our Pharmaceutical Quality Program for more info.
This product is non-returnable.
Availability:
In stock
Only 100 left
MPN
131390
Boehringer Ingelheim Vetera GoldXP Equine Vaccine 1 mL/1 Dose
- Protects against EIV, EHV (EHV-1 and EHV-4), EEE, WEE, Tetanus and West Nile Virus in 1 mL dose, offering the ultimate in convenience and protection
- At least 6 month duration of immunity against equine influenza (Ohio/03)
- At least 12 month WNV duration of immunity
- Safe for use in horses as young as 4 months of age, including pregnant mares
- Contains equine origin 2005 West Nile Virus isolate (E159™) - the strain most likely to infect horses today
- Ohio/03 (Clade 1), Richmond/07 (Clade 2) and Kentucky/95 equine influenza strains as recommended by the Expert Surveillance Panel on Equine Influenza
- Unique purification process and adjuvant formulation minimizes non-relevant protein presented to the immune system
- Available in single dose pre-filled syringes or color-coded 10 dose vials
Features
- Contains 9 antigens in one vaccine
- Includes Ohio/03 (Clade 1), Kentucky/95, and Richmond/07 (Clade 2) equine influenza strains
- Contains EHV-1 and EHV-4
- Includes a unique North American Equine E159™ West Nile Virus strain
- Incorporates the Carbimmune® adjuvant formulation
- Ultrafil® purification technology
- At least 6 month duration of immunity against equine influenza (Ohio/03)
- At least 12 month WNV duration of immunity
- Safe for use in horses as young as 4 months of age, including pregnant mares
Benefits
- Unique 8-way protection in one vaccine
- Contains relevant influenza viruses, including Clade 1 and Clade 2 strains
- Protection against both EIV and EHV
- Contains equine origin 2005 West Nile Virus isolate (E159™) - the strain most likely to infect horses today.
- Dual phase system delivers both rapid and long-lasting immunity
- Safe, high-quality vaccines
Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.
Item Number | BOE147 |
---|---|
MPN | 131390 |
UPC | 012315137197 |
Weight | 1.000000 |
Brand | Boehringer Ingelheim |
Item Returns | This item can be returned |
Write Your Own Review